AAV-mediated gene therapy improving mitochondrial function provides benefit in age-related macular degeneration models. (2022)
Attributed to:
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ctm2.952
PubMed Identifier: 35988157
Publication URI: http://europepmc.org/abstract/MED/35988157
Type: Journal Article/Review
Volume: 12
Parent Publication: Clinical and translational medicine
Issue: 8
ISSN: 2001-1326